BlackRock Investment Management’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

BlackRock Investment Management’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-162	Closed	-$1K	–	4184
2016 Q1	$1K	Hold	162	–	–	﹤0.01%	4045
2015 Q4	$2K	Hold	162	–	–	﹤0.01%	4035
2015 Q3	$4K	Hold	162	–	–	﹤0.01%	4005
2015 Q2	$6K	Buy	+162	New	+$6.4K	﹤0.01%	3928

Other funds holding IMNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

IFS

Ifrah Financial Services Little Rock, Arkansas $409M AUM 28.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Investment Management's IMNP Position: Q2 2016 in Review

BlackRock Investment Management sold out of Immune Pharmaceuticals Inc. (IMNP) in Q2 2016, closing a stake of 162 shares — an estimated $1K sold.

BlackRock Investment Management first reported a position in IMNP in Q2 2015 and held it in 4 quarters. The position peaked at $6K in Q2 2015. 11 funds tracked by Wall St. Rank hold IMNP as of Q2 2016.

BlackRock Investment Management reported no remaining Immune Pharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 162 Immune Pharmaceuticals Inc. shares in Q2 2016, an estimated $1K.
BlackRock Investment Management first reported a position in Immune Pharmaceuticals Inc. in Q2 2015 and held it in 4 quarters.
BlackRock Investment Management's Immune Pharmaceuticals Inc. position peaked at $6K in Q2 2015.
11 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.